Terms: = Lung cancer AND ERCC4, XPF, 2072, ENSG00000175595, Q92889 AND Clinical Outcome
3 results:
1. Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy.
Zhang R; Jia M; Xue H; Xu Y; Wang M; Zhu M; Sun M; Chang J; Wei Q
Sci Rep; 2017 Sep; 7(1):10702. PubMed ID: 28878296
[TBL] [Abstract] [Full Text] [Related]
2. Polymorphisms in ERCC1 and xpf gene and response to chemotherapy and overall survival of non-small cell lung cancer.
Shi ZH; Shi GY; Liu LG
Int J Clin Exp Pathol; 2015; 8(3):3132-7. PubMed ID: 26045829
[TBL] [Abstract] [Full Text] [Related]
3. Role of ERCC1 variants in response to chemotherapy and clinical outcome of advanced non-small cell lung cancer.
Huang SJ; Wang YF; Jin ZY; Sun JY; Guo ZL
Tumour Biol; 2014 May; 35(5):4023-9. PubMed ID: 24370899
[TBL] [Abstract] [Full Text] [Related]
